Does Rallies show 13F holders for QDEL?

Yes. Rallies tracks hedge fund and 13F ownership data for QDEL, including fund names, share counts, latest tracked quarter, and position changes when available.

Is QDEL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for QDEL. It does not provide personalized investment advice.

QDEL (QuidelOrtho Corporation Common Stock) Stock Analysis - Hedge Fund Holdings

QuidelOrtho Corporation Common Stock (QDEL) is a publicly traded Healthcare sector company. As of May 21, 2026, QDEL trades at $11.95 with a market cap of $739.19M and a P/E ratio of -0.67. QDEL moved +4.48% today. Year to date, QDEL is -60.38%; over the trailing twelve months it is -63.22%. Its 52-week range spans $9.92 to $49.45. Analyst consensus is neutral with an average price target of $12.03. Rallies surfaces QDEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns QDEL stock?

Hedge funds tracked by Rallies that own QDEL include Jana Partners, Maverick Capital, Mangrove Partners, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for QuidelOrtho Corporation Common Stock.

QDEL Key Metrics

Key financial metrics for QDEL
Metric	Value
Price	$11.95
Market Cap	$739.19M
P/E Ratio	-0.67
EPS	$-17.80
Dividend Yield	0.00%
52-Week High	$49.45
52-Week Low	$9.92
Volume	441
Avg Volume	0
Revenue (TTM)	$2.66B
Net Income	$-1.21B
Gross Margin	0.00%

Top Hedge Funds Holding QDEL

Jana Partners holds 1.03M shares of QDEL, changed -14.17% as of Jun 30, 2024.
Maverick Capital holds 59.78K shares of QDEL, changed -12.48% as of Dec 31, 2025.
Mangrove Partners holds 18.53K shares of QDEL, changed +0.00% as of Dec 31, 2024.
Bridgewater Associates holds 6.26K shares of QDEL, changed -71.49% as of Dec 31, 2024.
Pinebridge Investments holds 31 shares of QDEL, changed +0.00% as of Jun 30, 2023.

Latest QDEL News

QuidelOrtho Q1 revenue $620M, POC sales down 34% as guidance trimmed — May 5, 2026
QuidelOrtho Podcast Reveals 4,000 Congenital Syphilis Cases Despite Early-Stage Declines — Apr 23, 2026
QuidelOrtho Names Sisitsky Chief Legal Officer Effective March 23 — Mar 24, 2026
QuidelOrtho Launches High-Sensitivity Troponin for 0/1-Hour Cardiac Rule-Out Protocols — Feb 19, 2026
QuidelOrtho Signs Lifotronic Deal to Add 25 Assays Across 70+ Platforms — Feb 17, 2026

Recent QDEL Insider Trades

Busky Joseph M. bought 3.37K (~$79.74K) on Feb 13, 2026.
Strobeck Matthew bought 10.00K (~$239.59K) on Feb 13, 2026.
Busky Joseph M. bought 3.37K (~$79.74K) on Feb 13, 2026.

QDEL Analyst Consensus

6 analysts cover QDEL: 0 strong buy, 1 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.03.

Common questions about QDEL

Who owns QDEL stock?: Hedge funds tracked by Rallies that own QDEL include Jana Partners, Maverick Capital, Mangrove Partners, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for QuidelOrtho Corporation Common Stock.
Does Rallies show 13F holders for QDEL?: Yes. Rallies tracks hedge fund and 13F ownership data for QDEL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is QDEL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for QDEL. It does not provide personalized investment advice.